Analyst Ratings for HEALTHSOUTH (hls)
hls Rating Summary
hls Price Target Summary
- Highest: $29.00 (Stifel Nicolaus)
- Lowest: $23.00 (Jefferies)
- Average: $25.25
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.25 (-15.9%)
Avg. $ Target:
$25.25 (-15.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/26/2013 | Stifel Nicolaus | New Coverage | Buy (N/A) |
29.00 (N/A) |
25.81 | 30.04 | 16.39% | Details |
| 3/18/2013 | UBS » Updated 4/26/2013 |
Downgrade | Neutral (Buy) |
27.50 (27.00) |
25.10 | 30.04 | 19.68% | Details |
| 2/1/2013 | Deutsche Bank | Downgrade | Hold (Buy) |
25.00 (28.50) |
23.86 | 30.04 | 25.9% | Details |
| 10/31/2012 | JMP Securities | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
22.84 | 30.04 | 31.52% | Details |
| 7/27/2012 | Jefferies | Downgrade | Hold (Buy) |
23.00 (25.00) |
22.93 | 30.04 | 31.01% | Details |
| 6/4/2012 | Wells Fargo | Upgrade | Outperform (Market Perform) |
24.00 (N/A) |
18.54 | 30.04 | 62.03% | Details |
| 4/19/2012 | CRT Capital | Upgrade | Buy (N/A) |
24.50 (N/A) |
20.49 | 30.04 | 46.61% | Details |
| 1/3/2012 | BofA/Merrill Lynch | Downgrade | Underperform (N/A) |
N/A (N/A) |
17.67 | 30.04 | 70.01% | Details |
| 8/19/2011 | Mizuho Securities | New Coverage | Buy (N/A) |
23.00 (N/A) |
19.05 | 30.04 | 57.69% | Details |
| 2/11/2011 | Morgan Stanley | Upgrade | Overweight (N/A) |
N/A (N/A) |
22.59 | 30.04 | 32.98% | Details |
| 12/7/2010 | Morgan Keegan | New Coverage | Outperform (N/A) |
N/A (N/A) |
18.40 | 30.04 | 63.26% | Details |
| 11/15/2010 | Raymond James | Upgrade | Strong Buy (N/A) |
N/A (N/A) |
18.95 | 30.04 | 58.52% | Details |
| 9/23/2010 | Lazard Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
18.26 | 30.04 | 64.51% | Details |
